Status:
ACTIVE_NOT_RECRUITING
Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
University of Witwatersrand, South Africa
Conditions:
Adherence, Patient
TB
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
mHealth solutions designed to support affordable human resources for health, such as community health workers (CHWs), offer the opportunity to reimagine a patient-centered, system-level solution that ...
Detailed Description
Mycobacterium tuberculosis (TB) is the leading cause of death for persons living with HIV (PLWH) in South Africa (SA). Estimates suggest that if factoring in immediate lost to follow-up, a mere 52% of...
Eligibility Criteria
Inclusion
- Any person 18 years of age or older with pulmonary TB
- HIV positive
- Outpatient TB treatment (including short course RR-TB treatment) or admission \< 30 days is expected
Exclusion
- Unwilling or unable to provide informed consent, including inability to consent in one of the approved languages
- Patients who require hospitalization for TB treatment at treatment initiation
- Extrapulmonary or disseminated TB disease
- Severe clinical presentation: BMI \< 18 kg/m2 or a person unable to stand/walk
Key Trial Info
Start Date :
March 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT04298905
Start Date
March 10 2022
End Date
December 1 2025
Last Update
June 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kelly Lowensen
Baltimore, Maryland, United States, 21224-3750